What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis

Hiroyuki Murai

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)3-4
Number of pages2
JournalClinical and Experimental Neuroimmunology
Volume6
Issue number1
DOIs
Publication statusPublished - Feb 1 2015

Fingerprint

Myasthenia Gravis

All Science Journal Classification (ASJC) codes

  • Neuroscience (miscellaneous)
  • Immunology
  • Immunology and Microbiology (miscellaneous)
  • Clinical Neurology

Cite this

What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis. / Murai, Hiroyuki.

In: Clinical and Experimental Neuroimmunology, Vol. 6, No. 1, 01.02.2015, p. 3-4.

Research output: Contribution to journalEditorial

@article{268f55d96af74909bb996e4b5b8f5535,
title = "What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis",
author = "Hiroyuki Murai",
year = "2015",
month = "2",
day = "1",
doi = "10.1111/cen3.12186",
language = "English",
volume = "6",
pages = "3--4",
journal = "Clinical and Experimental Neuroimmunology",
issn = "1759-1961",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis

AU - Murai, Hiroyuki

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84922126911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922126911&partnerID=8YFLogxK

U2 - 10.1111/cen3.12186

DO - 10.1111/cen3.12186

M3 - Editorial

AN - SCOPUS:84922126911

VL - 6

SP - 3

EP - 4

JO - Clinical and Experimental Neuroimmunology

JF - Clinical and Experimental Neuroimmunology

SN - 1759-1961

IS - 1

ER -